HDAC8 and cancer: As our results suggest, dual inhibitors targeting both HDAC6 and HDAC8 may prove to be an effective anti-cancer agent as they would decrease the undesirable cytotoxic side effects from having to use multiple inhibitors while still providing the anti-cancer benefits of inhibiting HDAC6 and HDAC8.